Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta256
6 Related NICE guidance
Published
-
Dabigatran etexilate for the prevention of stroke or systemic embolism in atrial fibrillation. NICE technology appraisal guidance 249 (2012).
-
Thoracoscopic exclusion of the left atrial (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolism. NICE interventional procedure guidance 400 (2011).
-
Dronedarone for the treatment of non-permanent atrial fibrillation. NICE technology appraisal guidance 197 (2010).
-
Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism. NICE interventional procedure guidance 349 (2010).
-
The management of atrial fibrillation. NICE clinical guideline 36 (2006).